Molecular and Clinical Oncology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.9 | Q4 | 22.5% | 0.511 | Q3 | 61.7% |
| 2024 | 1.4 | Q4 | 17.8% | 0.466 | Q3 | 59.9% |
| 2023 | 1.4 | Q4 | 18.7% | 0.446 | Q3 | 61.2% |
| 2022 | 1.2 | 14.3% | 0.393 | Q3 | 58.7% | |
| 2021 | — | 25.2% | 0.393 | Q3 | 59.7% | |
| 2020 | — | — | 0.442 | Q3 | 62.5% | |
| 2019 | — | — | 0.213 | Q4 | 41.0% | |
| 2018 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2049-9469
ISSN
2049-9450
country
GBcoverage
2013, 2016-2026